|
Macarena Hernandez; aptaTargets S.L.; Madrid; Francisco Abad-Santos; Dept of Pharmacology and Toxicology; Faculty of Med; Univ Complutense; Madrid; Spain; Madrid; Spain; Ian Cotgreave; Karolinska Inst; Stockholm; Sweden; Jaime Gallego Sr.; Complejo Hospario de Navarra; Pamplona; Bernd Jilma; MEDICAL UNIVERSITY OF VIENNA; Vienna; Alan Flores Flores; Hosp Joan XXIII; Tarragona; Tudor G Jovin; Cooper Neurological Inst; Camden; NJ; José Vivancos; Hosp de la Princesa; Madrid; Spain; Maria Hernandez-Perez; Germans Trias i Pujol Hosp; Barcelona; Carlos A Molina; HOSPITAL VALL D HEBRON; Barcelona; Joan Montaner; Hosp Macarena Seville; IBIS; seville; JOAQUIN CASARIEGO; Aldebaran Res Development SL; Majadahonda; Mads Dalsgaard; Cureteq; Frederiksberg; David S Liebeskind; Erik Cobo; UCLA; Los Angeles; CA; Maria del Mar Castellanos; Hosp Juan Canalejo; LA Coruña; Spain; Pedro Cardona; BELLVITGE HOSPITAL; Barcelona; Jaime Masjuan; HOSPITAL UNIVERSITARIO RAMN Y CAJAL; Madrid; Spain; Francisco Moniche Sr.; HOSPITAL VIRGEN DEL ROCIO; Seville; Jose Tembl; HOSPITAL VIRGEN DEL ROCIO; Seville; Valencia; Mikel Terceño; HOSPITAL VIRGEN DEL ROCIO; Seville; Valencia; Girona; Juan F Arenillas; HOSPITAL CLINICO UNIV VALLADOLID; Valladolid; Patricia Calleja; Hosp 12 de Octubre; Madrid; Spain; Lionel Calviere; CHU RANGUEIL; Toulouse; France; Jean Marc M Olivot; HOPITAL TOULOUSE PURPAN; Toulouse; France; Hilde Henon; Univ of Lille; Lille; France; Mikael Mazighi; Fondation Rothschild; Paris; France; Marc Ribo; HOSPITAL VALL D HEBRON; Barcelona; Spain
|